IMM 20.3% 35.5¢ immutep limited

News: Prima BioMed CEO comments on CVac phase II

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.